ApprovalTrail

Approval · Notice of Compliance 22308 · 2019

TECFIDERA: Notice of Compliance 22308

Issued June 19, 2019

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
22308
Date
June 19, 2019
Company
Biogen Canada IncToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Product Monograph update to include information regarding the use of vaccines during treatment

Products in this notice

BrandDINStatus today
TECFIDERANot yet assigned—

Medicinal ingredients